45 min
A Discussion with Sonja Haut The Sustainable Leading Edge Presented by FigBytes
-
- Technology
In this third episode of The Sustainable Leading Edge podcast, FigBytes Head of Sustainability, Kate Cacciatore talks with Sonja Haut, Head of Impact Valuation at the multinational pharmaceutical company, Novartis, which is headquartered in Basel, Switzerland.
Sonja is the author of the new book, The Case for Impact: A Guide to Creating Value in a World of Social and Environmental Challenges, which has been described as a “clarion call for the adoption of impact measurement” and “an essential guide for those who want to understand the importance of impact in staying ahead of the curve”. Sonja’s pioneering work in the practice of impact valuation is immensely valuable to the field of Sustainability and to anyone seeking to learn about the state of the art when it comes to turning an organization’s purpose and its desire for positive impact into reality.
During the discussion, Sonja tells the story of her journey into the field of Impact Valuation within Novartis, building on her background as a mathematician and her professional roles in IT and Accounting. She shares her experience of the first pilots she led in Kenya and China, and how early methodologies for Environmental Profit & Loss statements began to be applied to considerations around social impact, notably on the social impact of medicines, which is at the heart of Novartis’ purpose “to reimagine medicine to improve and extend people's lives”.
Along the way, Sonja talks about the key ingredients in the process that enabled her and her colleagues to scale up the approach across different countries – guided by a framing of the four capitals: financial, natural, social and human – leading to an aggregated view of the social, environmental and economic impact of Novartis as a whole. This impact is expressed in monetary terms in their annual integrated company reports, thus bringing externalities from the supply chain into the picture and providing a solid basis for meaningful stakeholder dialogue, forward-thinking strategic plans and purpose-driven decision-making.
Finally, Sonja shares her thoughts on how emerging standards for Sustainability disclosures, such as those being developed by the International Sustainability Standard’s Board (ISSB), and the field of Impact Valuation are likely to converge in the future around sector-specific material issues, key performance indicators and data that illustrate tangible outcomes and impacts in the real world. She also shares her vision for the Impact Economy of the future and how Impact Valuation can serve as a practical tool and a common language to enable businesses, governments, civil society and investors to co-create value that recouples the interests of business and society.
To discover more about Sonja’s book, The Case for Impact, click here: https://www.amazon.com/Case-Impact-Creating-Environmental-Challenges-ebook/dp/B0BMNGRY7G
To access the many resources and use cases published by Novartis in their “Virtual Exhibition”, click here: https://www.cci-summit.com/
In this third episode of The Sustainable Leading Edge podcast, FigBytes Head of Sustainability, Kate Cacciatore talks with Sonja Haut, Head of Impact Valuation at the multinational pharmaceutical company, Novartis, which is headquartered in Basel, Switzerland.
Sonja is the author of the new book, The Case for Impact: A Guide to Creating Value in a World of Social and Environmental Challenges, which has been described as a “clarion call for the adoption of impact measurement” and “an essential guide for those who want to understand the importance of impact in staying ahead of the curve”. Sonja’s pioneering work in the practice of impact valuation is immensely valuable to the field of Sustainability and to anyone seeking to learn about the state of the art when it comes to turning an organization’s purpose and its desire for positive impact into reality.
During the discussion, Sonja tells the story of her journey into the field of Impact Valuation within Novartis, building on her background as a mathematician and her professional roles in IT and Accounting. She shares her experience of the first pilots she led in Kenya and China, and how early methodologies for Environmental Profit & Loss statements began to be applied to considerations around social impact, notably on the social impact of medicines, which is at the heart of Novartis’ purpose “to reimagine medicine to improve and extend people's lives”.
Along the way, Sonja talks about the key ingredients in the process that enabled her and her colleagues to scale up the approach across different countries – guided by a framing of the four capitals: financial, natural, social and human – leading to an aggregated view of the social, environmental and economic impact of Novartis as a whole. This impact is expressed in monetary terms in their annual integrated company reports, thus bringing externalities from the supply chain into the picture and providing a solid basis for meaningful stakeholder dialogue, forward-thinking strategic plans and purpose-driven decision-making.
Finally, Sonja shares her thoughts on how emerging standards for Sustainability disclosures, such as those being developed by the International Sustainability Standard’s Board (ISSB), and the field of Impact Valuation are likely to converge in the future around sector-specific material issues, key performance indicators and data that illustrate tangible outcomes and impacts in the real world. She also shares her vision for the Impact Economy of the future and how Impact Valuation can serve as a practical tool and a common language to enable businesses, governments, civil society and investors to co-create value that recouples the interests of business and society.
To discover more about Sonja’s book, The Case for Impact, click here: https://www.amazon.com/Case-Impact-Creating-Environmental-Challenges-ebook/dp/B0BMNGRY7G
To access the many resources and use cases published by Novartis in their “Virtual Exhibition”, click here: https://www.cci-summit.com/
45 min